Page last updated: 2024-09-05

organophosphonates and Keratoconjunctivitis

organophosphonates has been researched along with Keratoconjunctivitis in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	4 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Fujimoto, T; Fukushima, K; Hanaoka, N; Hazama, M	1
Gambotto, A; Gordon, YJ; Nwanegbo, EC; Romanowski, EG	1
Araullo-Cruz, T; Gordon, YJ; Romanowski, EG	1
Gordon, YJ; Romanowski, EG	1
Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R	2

Trials

2 trial(s) available for organophosphonates and Keratoconjunctivitis

Article	Year
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:10 Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome	2001
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology, 2002, Volume: 109, Issue:5 Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Conjunctiva; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Eyelids; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Safety	2002

Article

Year

Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.

Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:10

Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome

2001

The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.

Ophthalmology, 2002, Volume: 109, Issue:5

Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Conjunctiva; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Eyelids; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Safety

2002

Other Studies

4 other study(ies) available for organophosphonates and Keratoconjunctivitis

Article	Year
Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir. Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1 Topics: Adenoviridae Infections; Adenovirus Infections, Human; Cystitis; Cytosine; Humans; Immunocompromised Host; Keratoconjunctivitis; Mastadenovirus; Organophosphonates	2022
Efficacy of topical immunoglobulins against experimental adenoviral ocular infection. Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:9 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cell Culture Techniques; Cidofovir; Conjunctiva; Cornea; Cytosine; Disease Models, Animal; Epithelial Cells; Eye Infections, Viral; Flow Cytometry; Immunoglobulins, Intravenous; Immunologic Factors; Keratoconjunctivitis; Organophosphonates; Rabbits; Treatment Outcome; Virus Cultivation; Virus Replication; Virus Shedding	2007
Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Investigative ophthalmology & visual science, 1994, Volume: 35, Issue:12 Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Female; Humans; Keratoconjunctivitis; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Rabbits; Virus Replication; Virus Shedding	1994
Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model. Investigative ophthalmology & visual science, 2000, Volume: 41, Issue:2 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Female; Keratoconjunctivitis; Organophosphonates; Organophosphorus Compounds; Rabbits; Viral Plaque Assay; Virus Cultivation; Virus Replication; Virus Shedding	2000